Android Apple

Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio

By Yahoo! Finance   |   5 months ago
Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio

Tectonic Therapeutic completes reverse merger with Avrobio, now trading on Nasdaq as Tectonic Therapeutic (TECX). The new company raised $130.7m in a private placement, ensuring cash reserves of $181m till mid-2027.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.